...
首页> 外文期刊>Journal of the American Chemical Society >The N-terminal Region of Amyloid β Controls the Aggregation Rate and Fibril Stability at Low pH Through a Gain of Function Mechanism
【24h】

The N-terminal Region of Amyloid β Controls the Aggregation Rate and Fibril Stability at Low pH Through a Gain of Function Mechanism

机译:淀粉样蛋白β的N末端区域通过功能机理的获得控制低pH下的聚集速率和原纤维稳定性。

获取原文
获取原文并翻译 | 示例
           

摘要

Alzheimer's disease is linked to a pathological polymerization of the endogenous amyloid β-peptide (Aβ) that ultimately forms amyloid plaques within the human brain. We used surface plasmon resonance (SPR) to measure the kinetic properties of Aβ fibril formation under different conditions during the polymerization process. For all polymerizationprocesses, a critical concentration of free monomers, as defined by the dissociation equilibrium constant (K_D), is required for the buildup of the polymer, for example, amyloid fibrils. At concentrations below the K_D, polymerization cannot occur. However, the K_D for Aβ has previously been shown to be several orders of magnitude higher than the concentrations found in the cerebrospinal and interstitial fluids of the human brain, and the mechanism by which Aβ amyloid forms in vivo has been a matter of debate. Using SPR, we found that the K_D of Aβ dramatically decreases as a result of lowering the pH. Importantly, this effect enables Aβ to polymerize within a picomolar concentration range that is close to the physiological Aβ concentration within the human brain. The stabilizing effect is dynamic, fully reversible, and notably pronounced within the pH range found within the endosomal and lysosomal pathways. Through sequential truncation, we show that the N-terminal region of Aβ contributes to the enhanced fibrillar stability due to a gain of function mechanism at low pH. Our results present a possible route for amyloid formation at very low Aβ concentrations and raise the question of whether amyloid formation in vivo is restricted to a low pH environment. These results have general implications for the development of therapeutic interventions.
机译:阿尔茨海默氏病与内源性淀粉样蛋白β肽(Aβ)的病理聚合反应有关,后者最终在人脑内形成淀粉样蛋白斑块。我们使用表面等离子体共振(SPR)来测量聚合过程中不同条件下Aβ原纤维形成的动力学性能。对于所有聚合方法,对于聚合物例如淀粉状蛋白原纤维的积聚,需要临界浓度的游离单体,其由解离平衡常数(K_D)定义。在低于K_D的浓度下,不会发生聚合。然而,先前已证明Aβ的K_D比人脑的脑脊髓和组织液中的浓度高几个数量级,而Aβ淀粉样蛋白在体内形成的机制尚有争议。使用SPR,我们发现由于降低了pH,Aβ的K_D急剧降低。重要的是,这种作用使Aβ能够在皮摩尔浓度范围内聚合,该浓度范围接近人脑内的生理Aβ浓度。稳定作用是动态的,完全可逆的,在内体和溶酶体途径内的pH范围内尤为明显。通过顺序截断,我们表明Aβ的N端区域有助于增强原纤维的稳定性,这是由于在低pH下获得了功能机制。我们的结果提出了在极低的Aβ浓度下形成淀粉样蛋白的可能途径,并提出了一个问题,即体内淀粉样蛋白的形成是否仅限于低pH环境。这些结果对治疗干预的发展具有普遍意义。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2014年第31期|10956-10964|共9页
  • 作者单位

    Department of Medical Biochemistry and Biophysics, Umea University, SE-901 87, Umea, Sweden;

    Department of Pharmacology and Clinical Neuroscience, Umea University, SE-901 85 Umea, Sweden;

    Department of Chemistry, Umea University, SE-901 87, Umea, Sweden;

    Department of Medical Biochemistry and Biophysics, Umea University, SE-901 87, Umea, Sweden;

    Department of Molecular Biology, Umea University, SE-901 87, Umea, Sweden;

    Department of Medical Biochemistry and Biophysics Umea University, SE-901 87, Umea, Sweden;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号